Home › Companies › Abbott Laboratories › 2025-2026
Compiled from SEC Form N-PX filings and Abbott Laboratories’s Form 8-K, filed April 27, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of April 24, 2026: 16 items on Abbott Laboratories’s Form 8-K, filed April 27, 2026: 2 approved · 14 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Abbott Laboratories in the interactive database Compare manager voting policies
These tallies are Abbott Laboratories’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Nita Ahuja | 1,355,031,895 | 2,769,947 | 2,308,000 | -- | 177,761,396 | 99.7% | Not verified | — |
| Elect Director: Claire Babineaux-Fontenot | 1,355,031,167 | 2,886,973 | 2,191,702 | -- | 177,761,396 | 99.7% | Not verified | — |
| Elect Director: Sally E. Blount | 1,340,491,010 | 16,504,318 | 3,114,514 | -- | 177,761,396 | 99% | Not verified | — |
| Elect Director: Robert B. Ford | 1,281,298,501 | 72,599,833 | 6,211,508 | -- | 177,761,396 | 95% | Not verified | — |
| Elect Director: Paola Gonzalez | 1,350,598,638 | 6,179,509 | 331,695 | -- | 177,761,396 | 99.5% | Not verified | — |
| Elect Director: Michelle A. Kumbier | 1,346,291,350 | 11,453,399 | 2,365,093 | -- | 177,761,396 | 99.1% | Not verified | — |
| Elect Director: Darren W. McDew | 1,350,511,200 | 6,363,222 | 3,235,420 | -- | 177,761,396 | 99.5% | Not verified | — |
| Elect Director: Nancy McKinstry | 1,289,618,114 | 68,049,468 | 2,442,260 | -- | 177,761,396 | 95% | Not verified | — |
| Elect Director: Michael G. O'Grady | 1,325,498,060 | 32,189,526 | 2,422,256 | -- | 177,761,396 | 98% | Not verified | — |
| Elect Director: Michael F. Roman | 1,338,763,530 | 18,363,024 | 2,983,288 | -- | 177,761,396 | 99% | Not verified | — |
| Elect Director: Daniel J. Starks | 1,291,460,783 | 66,299,714 | 2,349,345 | -- | 177,761,396 | 95% | Not verified | — |
| Elect Director: John G. Stratton | 1,330,379,819 | 27,314,174 | 2,415,849 | -- | 177,761,396 | 98% | Not verified | — |
| (2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's auditors. | 1,502,083,607 | 33,333,515 | 2,454,116 | -- | 0 | 98% | Approved | — |
| (3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vote is advisory and n | 1,228,911,693 | 126,315,146 | 4,883,003 | -- | 177,761,396 | 91% | Approved | — |
| (4) The shareholders voted to approve the Abbott Laboratories 2026 Incentive Stock Program, with 95.82 percent of the votes cast voting "For" the proposal. | 1,303,349,739 | 52,296,340 | 4,463,763 | -- | 177,761,396 | 96% | Not verified | — |
| (5) The shareholders voted to approve the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees, with 99.33 percent of the votes cast voting "For" the proposal. | 1,351,008,136 | 6,111,112 | 2,990,594 | -- | 177,761,396 | 99.5% | Not verified | — |
Source: Abbott Laboratories, Form 8-K, filed with the SEC on April 27, 2026 — read the filing on EDGAR.
Each item below shows how the 1,673 asset managers that disclosed a Abbott Laboratories vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 10 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: C. Babineaux-Fontenot
Abbott Laboratories’s own tally for this item (“Elect Director: Claire Babineaux-Fontenot”): 1,355,031,167 for, 2,886,973 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,520,558 for, 2,306 against, 90,483 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,509 | 15 | 12 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 10 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: N. Ahuja
Abbott Laboratories’s own tally for this item (“Elect Director: Nita Ahuja”): 1,355,031,895 for, 2,769,947 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,530,427 for, 2,305 against, 90,484 abstained, 2,202 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,509 | 14 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 10 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: P. Gonzalez
Abbott Laboratories’s own tally for this item (“Elect Director: Paola Gonzalez”): 1,350,598,638 for, 6,179,509 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,520,533 for, 2,324 against, 90,490 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,484 | 33 | 19 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 10 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: R. B. Ford
Abbott Laboratories’s own tally for this item (“Elect Director: Robert B. Ford”): 1,281,298,501 for, 72,599,833 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 539,024,822 for, 1,148,040 against, 440,484 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,129 | 393 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,542 | 157 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 10 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: S. E. Blount
Abbott Laboratories’s own tally for this item (“Elect Director: Sally E. Blount”): 1,340,491,010 for, 16,504,318 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,346,985 for, 185,744 against, 90,488 abstained, 2,202 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,429 | 91 | 17 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 9 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: M. A. Kumbier
Abbott Laboratories’s own tally for this item (“Elect Director: Michelle A. Kumbier”): 1,346,291,350 for, 11,453,399 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,520,512 for, 2,352 against, 90,484 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,463 | 61 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 10 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: D. W. McDew
Abbott Laboratories’s own tally for this item (“Elect Director: Darren W. McDew”): 1,350,511,200 for, 6,363,222 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,500,791 for, 31,936 against, 90,489 abstained, 2,202 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,484 | 34 | 18 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 10 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: N. McKinstry
Abbott Laboratories’s own tally for this item (“Elect Director: Nancy McKinstry”): 1,289,618,114 for, 68,049,468 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,206,990 for, 315,873 against, 90,484 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,152 | 371 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: M. G. O'Grady
Abbott Laboratories’s own tally for this item (“Elect Director: Michael G. O'Grady”): 1,325,498,060 for, 32,189,526 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,170,392 for, 352,473 against, 90,484 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,343 | 182 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 9 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: M. F. Roman
Abbott Laboratories’s own tally for this item (“Elect Director: Michael F. Roman”): 1,338,763,530 for, 18,363,024 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,520,467 for, 2,393 against, 90,486 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,418 | 102 | 15 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 9 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: D. J. Starks
Abbott Laboratories’s own tally for this item (“Elect Director: Daniel J. Starks”): 1,291,460,783 for, 66,299,714 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 539,840,401 for, 682,462 against, 90,484 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,210 | 313 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of 12 Directors: J. G. Stratton
Abbott Laboratories’s own tally for this item (“Elect Director: John G. Stratton”): 1,330,379,819 for, 27,314,174 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 251 asset managers below reported 540,399,821 for, 123,040 against, 90,484 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,408 | 113 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Combines 14 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees
Abbott Laboratories’s own tally for this item (“(5) The shareholders voted to approve the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees, with 99.33 percent of the votes cast voting "For" the proposal.”): 1,351,008,136 for, 6,111,112 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Abbott Laboratories’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approve Omnibus Stock Plan” (14 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Approve Stock Compensation Plan” (9 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 276 asset managers below reported 540,919,419 for, 184,846 against, 3,839 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,489 | 33 | 15 | 0 | For |
| Capital Group | 73,622,688 | 0 | 3,824 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 276 asset managers. See all 276 in the interactive database.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Approval of the Abbott Laboratories 2026 Incentive Stock Program
Abbott Laboratories’s own tally for this item (“(4) The shareholders voted to approve the Abbott Laboratories 2026 Incentive Stock Program, with 95.82 percent of the votes cast voting "For" the proposal.”): 1,303,349,739 for, 52,296,340 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 263 asset managers below reported 539,027,593 for, 1,186,245 against, 3,847 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,223 | 290 | 23 | 0 | For |
| Capital Group | 73,622,688 | 0 | 3,824 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 263 asset managers. See all 263 in the interactive database.
Combines 46 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: Say on Pay - An Advisory Vote on the Approval of Executive Compensation
Abbott Laboratories’s own tally for this item (“(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vo”): 1,228,911,693 for, 126,315,146 against — passed, per its Form 8-K filed April 27, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vote is advisory and n”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Abbott Laboratories’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “SECTION 14A EXECUTIVE COMPENSATION” (34 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Say on Pay - An Advisory Vote on the Approval of Executive Compensation More Details” (3 managers, 7,310 for, 13,488 against); “Compensation” (2 managers, 45,873 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,817,899 | 610 | 26 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Fund voting reports, all 235 managers: 538,812,624 for, 1,336,347 against, 86,087 abstained, 2,203 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 68,586,454 | 11,476 | 0 | 0 | For |
| Capital Research Global Investors | 52,606,991 | 0 | 0 | 0 | For |
| Capital Group | 41,042,869 | 0 | 3,824 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 38,721,368 | 0 | 0 | 0 | For |
| State Street | 29,410,831 | 505,861 | 0 | 0 | For |
| Wellington | 29,064,210 | 0 | 0 | 0 | For |
| T. Rowe Price | 22,476,273 | 44,748 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 18,718,193 | 0 | 0 | 0 | For |
| Vanguard | 17,560,082 | 0 | 0 | 0 | For |
| Northern Trust | 16,908,551 | 133,801 | 0 | 0 | For |
| Janus Henderson | 16,541,690 | 5,000 | 0 | 0 | For |
| Invesco | 15,975,054 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 14,423,362 | 0 | 0 | 0 | For |
| Charles Schwab | 14,155,726 | 0 | 0 | 0 | For |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13,587,118 | 0 | 0 | 0 | For |
| UBS | 0 | 12,653,148 | 0 | 0 | Against |
| AllianceBernstein | 11,135,400 | 0 | 0 | 0 | For |
| Nuveen | 11,123,158 | 5,336 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 9,650,935 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 8,431,687 | 0 | 0 | 0 | For |
| Goldman Sachs | 8,122,733 | 0 | 0 | 0 | For |
| Amundi | 0 | 8,047,225 | 0 | 0 | Against |
| Legal & General Investment Management Ltd | 208,674 | 7,629,786 | 0 | 0 | Against |
| Grantham, Mayo, Van Otterloo & Co. LLC | 7,832,235 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 35 | 7,772,654 | 0 | 0 | Against |
Institutional-manager reports, all 1,439 managers: 728,863,241 for, 85,464,452 against, 1,762 withheld, 72,886 abstained, 420,256 not voted, 79,947 mixed, 9,869 unknown. Showing the 25 largest; see all in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: Ratification of Ernst & Young LLP As Auditors
Abbott Laboratories’s own tally for this item (“(2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's auditors.”): 1,502,083,607 for, 33,333,515 against — passed, per its Form 8-K filed April 27, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's auditors.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 256 asset managers below reported 540,531,873 for, 39,585 against, 108,983 abstained, 2,202 not voted, 9,869 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,348 | 180 | 10 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 256 asset managers. See all 256 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of April 25, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 183,818,535 |
| 2 | Capital Group | 73,622,688 |
| 3 | BlackRock | 54,897,598 |
| 4 | Fidelity | 40,257,349 |
| 5 | State Street | 21,063,699 |
| 6 | INVESTMENT CO OF AMERICA | 14,216,191 |
| 7 | JPMorgan | 13,169,439 |
| 8 | Charles Schwab | 10,426,149 |
| 9 | MFS | 10,291,379 |
| 10 | TIAA | 8,690,594 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | BlackRock | 68,597,930 |
| 2 | Capital Research Global Investors | 52,606,991 |
| 3 | Capital Group | 41,046,693 |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 38,721,368 |
| 5 | State Street | 29,916,692 |
| 6 | Wellington | 29,065,090 |
| 7 | T. Rowe Price | 22,521,021 |
| 8 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 18,718,193 |
| 9 | Vanguard | 17,560,082 |
| 10 | Northern Trust | 17,042,352 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to Abbott Laboratories for the 2025-2026 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Abbott Laboratories's shareholder meeting held April 24, 2026, in the 2025-2026 proxy season, 1,673 asset managers reported how they voted on 16 ballot items in their SEC Form N-PX filings, covering 20,985 separate fund positions. On the most widely held item on that ballot — Say on Pay - An Advisory Vote on the Approval of Executive Compensation — Abbott Laboratories's filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Abbott Laboratories's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 27, 2026.
Abbott Laboratories proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.